Treatment of invasive fungal sinusitis with liposomal amphotericin B: A report of four cases

Journal of the Medical Association of Thailand

Volumn 84, Issue 4, 2001, Pages 593-601

  Sungkanuparph, S ^a   Kunachak, S ^a   Cheewaruangroj, W ^a   Sathapatayavongs, B ^a   Luxameechanporn, T ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Invasive Fungal Sinusitis; Liposomal Amphotericin B; Treatment

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX;

ADULT; AGED; ARTICLE; ASPERGILLOSIS; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MUCORMYCOSIS; SINUSITIS; SURGICAL APPROACH; TREATMENT INDICATION;

ADULT; AGED; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ASPERGILLOSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; LIPOSOMES; MALE; MIDDLE AGED; MUCORMYCOSIS; SINUSITIS;

EID: 0034853282     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Invasive mold sinusitis: 17 Cases in immunocompromised patients and review of the literature
2. An approach to fulminant invasive fungal rhinosinusitis in the immunocompromised host
3. Mucormycosis in diabetes
4. Clinical presentation of invasive aspergillosis
5. Lipid formulations of amphotericin B: Clinical efficacy and toxicities
6. Lipid formulations of amphotericin B: Recent progress and future directions
7. AmBisome (liposomal amphotericin B): A comparative review
8. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia
9. Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients
10. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections
11. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients
12. Liposomal amphotericin (AmBisome) is safe in bone marrow transplantation for primary immunodeficiency
13. Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data
14. Liposomal amphotericin B (AnBisome) compared with amphtericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis
15. The use of lipid formulations of amphotericin B for systemic fungal infections
16. Favorable outcome of orbital nasal sinus mucormycosis complicating the induction treatment of acute lymphoblastic leukemia
17. Drug treatment of invasive aspergillosis of the paranasal sinuses
18. Fungal sinusitis
19. A new classification and diagnostic criteria for invasive fungal sinusitis
20. Rhinocerebral and systemic mucormycosis. Clinical experience with 36 cases
21. Appearance of fungal sinusitis on computed tomography
22. Craniofacial mucormycosis: Assessment with CT
23. Liposomal amphotericin B as early empiric antimycotic therapy of pneumonia in granulocytopenic patients
24. Liposomal and lipid-based formulations of amphotericin B